Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model
Amin Afkhami-Poostchi, Mansour Mashreghi, Mehrdad Iranshahi, Maryam Moghaddam Matin
Topics & Concepts
Genetically engineeredColon carcinomaGenetically modified organismEscherichia coliChemistryInflammationPharmacologyCancer researchColorectal cancerBiologyBiochemistryMolecular biologyImmunologyGeneCancerGeneticsCancer Research and TreatmentsPharmacological Effects of Natural CompoundsBioactive Compounds and Antitumor Agents